E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy
Sudha Visvanathan, Carrie Wagner, Jeannie Rojas, Jonathan Kay, Bhaskar Dasgupta, Eric L. Matteson, Michael Mack, Daniel G. Baker, Mahboob U. Rahman
Dive into the research topics of 'E-selectin, interleukin 18, serum amyloid A, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy'. Together they form a unique fingerprint.